.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Argus Health
AstraZeneca
Express Scripts
Chubb
Harvard Business School
Moodys
Merck
Dow

Generated: June 28, 2017

DrugPatentWatch Database Preview

ZEFAZONE Drug Profile

« Back to Dashboard

Which patents cover Zefazone, and when can generic versions of Zefazone launch?

Zefazone is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in ZEFAZONE is cefmetazole sodium. There are three drug master file entries for this compound. Additional details are available on the cefmetazole sodium profile page.

Summary for Tradename: ZEFAZONE

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list26
Patent Applications: see list248
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZEFAZONE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
ZEFAZONE
cefmetazole sodium
INJECTABLE;INJECTION050637-001Dec 11, 1989DISCNYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
ZEFAZONE IN PLASTIC CONTAINER
cefmetazole sodium
INJECTABLE;INJECTION050683-002Dec 29, 1992DISCNYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
ZEFAZONE
cefmetazole sodium
INJECTABLE;INJECTION050637-002Dec 11, 1989DISCNYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
ZEFAZONE IN PLASTIC CONTAINER
cefmetazole sodium
INJECTABLE;INJECTION050683-001Dec 29, 1992DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Daiichi Sankyo
Cipla
Citi
Queensland Health
Novartis
US Army
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot